Public health is becoming a team sport | Deloitte US has been saved
Limited functionality available
By David Betts, principal, and Elizabeth Berkey Cathles, senior manager, Public Health Transformation, Deloitte Consulting LLP
Since early 2020, the public-health sector has responded to a steady flow of pathogens—from COVID-19 to monkeypox to polio, and most recently, to Ebola.1 (Influenza and bird flu may be on the horizon.)2 This persistent threat—layered with concurrent responses—reinforces the need for public health to be a team sport where different types of players work together to defeat new and formidable opponents.
Prior to COVID-19, federal, state, and local public health leaders typically developed a deep understanding of a pathogen, but also relied on the commercial market to execute widespread testing and vaccinations. But those players were unable to stay within these expected boundaries once COVID-19 became a pandemic, and the traditional public-health architecture buckled under the stress. Public health officials suddenly found themselves operating in a much more complex environment and working with a broader set of players, some for the first time. Moreover, many public health departments were ill prepared, unfunded or underfunded, inexperienced, and/or understaffed as the pandemic unfolded. Still, they stood up programs (e.g., testing, contact-tracing, mass vaccinations) on an unprecedented scale. There were successes and challenges.
Although managing multiple health emergencies simultaneously is not new for public health, the number of large outbreaks has been on the rise, and many public health agencies are taxed and stressed. If regularly emerging pathogens become the norm, public health agencies will need the infrastructure and the resources to respond swiftly and effectively. They will likely also need to work hand-in-hand with a broader ecosystem of actors, public- and private-sector alike, to build a resilient system that is more prepared for the unexpected. On October 18, the White House said it would invest in “critical multi-lateral institutions” as part of its strategy to enhance the country’s pandemic preparedness.3
The benefits of inter-agency partnerships
Public health leaders should try to become more comfortable in working with a broader set of players. They should also build patterns and systems to support interactions with those players. Many public-health departments have experienced the benefits of working with outside agencies and organizations and local jurisdictions. Most have developed inter-agency partnerships across jurisdictions that have led to greater coordination and better outcomes. Some agencies have added local universities to their advisory boards. Forging deeper and more consistent relationships with the commercial sector could help public health departments increase capacity and improve response times.
The pandemic led to a new way of thinking. The commercial market, for example, introduced new tools and technologies to detect, prevent, and treat COVID-19. Public health officials, however, have historically held tests to a high standard and had to take a leap of faith that their commercial counterparts would deliver accurate tests at scale. The public health sector now has experience in leveraging tools that had not traditionally been used so broadly. Contract-tracing apps, for example, warned the public about potential exposures. They also provided insight into how the risk was perceived by gender, generation, and race.4
As we emerge from the COVID-19 pandemic, public health has an opportunity to be more proactive in determining roles that can and should be played by outside organizations. For example, how much can public health departments rely on local health systems or other private-sector players to carry out important public health activities during emergencies?
Successful private-public partnerships
Early last summer, as monkeypox was emerging as a potential threat, the Department of Health and Human Services (HHS)—through the Centers for Disease Control and Prevention (CDC)—shipped virus tests to five commercial laboratories in an effort to quickly ramp up testing capacity nationwide. At the same time, the Food and Drug Administration (FDA) gave hospitals and health systems the green light to develop their own high-quality tests, which has been successful.5
Another example of this public-private partnership is Healthy Davis Together, a pandemic response program launched by the city of Davis, California, the University of California’s Davis campus, and local businesses. The program provided regular COVID-19 testing, promoted vaccinations, supported local businesses, and aggregated and shared data. A recent analysis concluded the program helped reduce infection rates by 60%.6
There are many other examples of successful private-public partnerships. However, some public health leaders might worry that such arrangements could require them to forfeit control. But working with a broad set of players can help extend resources and responsibilities and could help ensure a faster and more efficient response to public health emergencies.
Four factors that could strengthen multi-layered public health responses
Here are some of the lessons public health has learned since COVID-19 emerged…and some of the challenges it continues to grapple with:
Many of our Deloitte colleagues are heading to Boston next month to participate in the American Public Health Association’s annual meeting where collaboration will be a predominant theme.
Public health officials have learned a lot since COVID-19 surfaced nearly three years ago. Collaboration has helped make the public health team bigger, stronger, and more diverse. There also appears to be less concern about who has the ball at any point in the game. As this team continues to work and practice together, it will likely only get better at the game, and more effective when it encounters new opponents.
Acknowledgements: Cecelia Gondek, Carrie Holsinger
This publication contains general information only and Deloitte is not, by means of this publication, rendering accounting, business, financial, investment, legal, tax, or other professional advice or services. This publication is not a substitute for such professional advice or services, nor should it be used as a basis for any decision or action that may affect your business. Before making any decision or taking any action that may affect your business, you should consult a qualified professional advisor.
Deloitte shall not be responsible for any loss sustained by any person who relies on this publication.
Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as “Deloitte Global”) does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the “Deloitte” name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see www.deloitte.com/about to learn more about our global network of member firms.
Copyright © 2022 Deloitte Development LLC. All rights reserved.
1. US to begin screening air passengers from Uganda for Ebola, New York Times, October 6, 2022
2. Bird flu ‘prevention zone’ declared across Great Britain, October 17, 2022
3. Fact Sheet: Biden-Harris Administration releases strategy to strengthen health security and prepare for biothreats, The White House, October 18, 2022
4. Perception and use of COVID contact-tracing mobile applications in New York State, Association for Information Science & Technology, October 14, 2022
5. HHS expanding monkeypox testing capacity to five commercial laboratories, HHS press release, June 22, 2022
6. Health Davis Together: Creating a model for community control of COVID-19, American Public Health Association, July 13, 2022
7. Monkeypox response relies on trade-offs without federal aid, Roll Call, September 28, 2022
8. Ten years after Sandy: Barriers to resilience, New York City Comptroller, October 13, 2022